% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@INPROCEEDINGS{Sauerwein:892914,
      author       = {Sauerwein, W and Hey-Hawkins, E and Wittig-Sauerwein, A and
                      Theisen, G and Wortmann, B and Gutberlet, Thomas},
      title        = {{T}reating cancer with neutrons – {O}ptions for {B}oron
                      {N}eutron {C}apture {T}herapy},
      reportid     = {FZJ-2021-02438},
      year         = {2021},
      note         = {virtual conference},
      abstract     = {Almost half a million people are newly diagnosed with
                      cancer every year in Germany. Despite the tremendous
                      progress that has been made across the various sciences
                      involved in the field of cancer diagnosis and therapy, it
                      remains a severe threat for every patient confronted with
                      such a diagnosis. Combination of chemical and radiation
                      therapy nowadays are the standard treatments to cure many
                      patients. Although neutrons have been applied here in
                      particular boron neutron capture therapy (BNCT) is
                      considered with great potential to cure against cancer as a
                      kind of “cellular surgery”. First experiments happened
                      in the early sixties and seventies but availability of
                      epithermal neutrons only at research neutron facilities
                      hampered its application. In recent years this situation for
                      the application of BNCT to patients is changing with the
                      advent of powerful accelerator-based neutron sources. First
                      projects have started at hospitals in Japan and similar
                      projects are underway in Finland, England and Italy. In
                      Germany the society for BNCT (DGBNCT e.V.) was founded
                      recently to promote this therapy.In this presentation the
                      state of the art in BNCT treatment and research will be
                      presented, the new BNCT projects worldwide and the efforts
                      in Europe and Germany to promote and establish the therapy
                      in the fight against cancer.},
      month         = {Jun},
      date          = {2021-06-08},
      organization  = {MLZ Conference 2021: Neutrons for Life
                       Sciences, Garching (Germany), 8 Jun
                       2021 - 11 Jun 2021},
      subtyp        = {After Call},
      cin          = {JCNS-HBS / JCNS-2 / PGI-4 / JARA-FIT},
      cid          = {I:(DE-Juel1)JCNS-HBS-20180709 / I:(DE-Juel1)JCNS-2-20110106
                      / I:(DE-Juel1)PGI-4-20110106 / $I:(DE-82)080009_20140620$},
      pnm          = {6G4 - Jülich Centre for Neutron Research (JCNS) (FZJ)
                      (POF4-6G4) / 632 - Materials – Quantum, Complex and
                      Functional Materials (POF4-632)},
      pid          = {G:(DE-HGF)POF4-6G4 / G:(DE-HGF)POF4-632},
      experiment   = {EXP:(DE-MLZ)NOSPEC-20140101},
      typ          = {PUB:(DE-HGF)6},
      url          = {https://juser.fz-juelich.de/record/892914},
}